Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Environmental chemistry is the study of chemical processes that occur in water, air, terrestrial and living environments, and the effects of human activity on them. It includes topics such as ...

Marine chemistry is the study of the chemical composition and chemical processes of the world’s oceans. Some of the key processes studied are the cycling of: inorganic and organic carbon ...

Mar. 26, 2025 — Researchers have developed a molecular system for controlled release of iron. They integrated ferrocene, a molecular sandwich that encloses an iron atom, with a carbon 'nanohoop ...

Mar. 26, 2025 — Researchers have developed a molecular system for controlled release of iron. They integrated ferrocene, a molecular sandwich that encloses an iron atom, with a carbon 'nanohoop ...

Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing maker's board and former U.S. Food and Drug Administration Commissioner Scott Gottlieb would take over as ...